ENVA Enova International Inc.

$ENVA goes to show how big the bank charter was for them. There’s a subprime lender with their bank charter and expanding their lending across the US in $PRL.TSX

$ENVA Adding. A bank charter was never going to move the needle that much for a company like enva that's able to command better and better finding terms the bigger and better they perform and they are exceptional performers in the space.

$ENVA Bearish — a −23% verdict wasn't about one dead bank deal, it was the market repricing Enova's entire charter strategy as a sunk cost. Their "we don't need a bank to grow" memo reads like a company discovering its moat was a paperwork fantasy.

$ENVA $CTNM $TRMD AFTER-HOURS MOVERS: Currently Higher After Earnings: - Radiant Logistics (RLGT) up 10.0% Currently Also Higher: - Boot Barn Holdings (BOOT) up 1.5% after positive Q2 pre-announcement ahead of investor conferences Currently Lower After Earnings: - Dave & Buster's Entertainment (PLAY) down 11.4% - Kestra Medical Technologies (KMTS) down 10.8% - The Children's Place (PLCE) down 1.2% Currently Also Lower: - Enova International (ENVA) down 19.8% after withdrawing application for Grasshopper deal - Contineum Therapeutics (CTNM) down 3.5% after announcing MOONLIGHT-1 trial did not achieve endpoint - TORM plc (TRMD) down 3.8% after equity offering.

$ENVA Enova withdraws application for proposed acquisition of Grasshopper Bancorp Enova International announced that it has withdrawn its applications with the Office of the Comptroller of the Currency and the Board of Governors of the Federal Reserve System related to the proposed acquisition of Grasshopper Bancorp. Throughout the application process, Enova has worked constructively and transparently with regulators, responding promptly and fully to requests and building an application that Enova believes satisfies the statutory criteria for approval. "After a thorough evaluation, we are confident that withdrawing our applications is the best decision for Enova and our shareholders. Bank regulatory guidelines and attitudes have not kept pace with the realities of meeting the credit needs of tens of millions of consumers and small businesses underserved by traditional banks. Regulators do not have clear standards for nonbanks that want to become banks and that serve customers whose credit needs today are met mostly outside of the banking system. Without clearly articulated standards, the process is susceptible to political pressure and outside advocacy, rather than being guided strictly by the statutory factors that should govern it," said Steve Cunningham, Enova's CEO.

$ENVA — NEW AFTER-HOURS COMPANY UPDATE: Enova withdrew its regulatory applications tied to the proposed acquisition of Grasshopper Bancorp, saying the bank-approval process lacked clear standards for nonbank applicants. Importantly, Enova reaffirmed 2026 guidance: full-year revenue growth of 20%–25% and adjusted EPS growth of 30%–35%. Management also said it plans to accelerate share repurchases through the remainder of 2026, with $349M remaining under its current authorization as of June 30.

$ENVA dumped ~23% after they yanked the Grasshopper bank apps. Crack 167.85 into Wed and this fade keeps rolling.

$ENVA had no choice but to buy at $168 today. If $LIF will move back up ill purge some of my shares to buy more $ENVA . EZ money

$ENVA -24% today after the company withdrew its regulatory applications for the Grasshopper Bancorp acquisition. No new financial trouble behind it though - management reaffirmed 2026 guidance and said it's accelerating buybacks instead. My screener shows the panic in the signals: Momentum Alignment and Volume Surge (7.8x average volume) both flipped Sell this morning, RSI down at 20.5 (Reversal Watch Buy), but Golden Cross has been running Buy for 315 days straight and hasn't moved. Still up about 41% over the past year despite today's drop. A scrapped deal vs. real business risk - which one is the market actually pricing here?

Moody’s Ratings affirmed Enova International’s B1 corporate family rating and B2 senior unsecured debt ratings on Friday, concluding its review for upgrade and changing the outlook to stable from under review. The review, initiated in December 2025 after Enova announced plans to acquire Grasshopper Bank, ended after the company withdrew its acquisition application on Sept. 14, 2026. Moody’s said Enova’s credit profile remains largely unchanged, supported by resilient consumer and SMB online lending businesses despite inflationary pressures and higher interest rates. Following the withdrawal, Enova plans to resume share buybacks at an accelerated pace. Moody’s expects strong earnings to support tangible common equity-to-tangible managed assets at 17%-22%. Ratings could be upgraded if Enova reduces legal and regulatory risks while maintaining strong profitability and capitalization above 20%. A downgrade could follow significant asset-quality deterioration. $ENVA

$ENVA Check out Longeveron! Phase 1 - All 10 babies were alive after 1 year with no heart transplant, standard of care, survival is 70-80%...follow up of 10 babies after 5 years all are alive with no heart transplant....SOC is 3 heart surgeries....treatment is SOC (3 heart surgeries) + the drug (laromestrocel) given after 2nd heart surgery LGVN market cap $20 million - $2 billion annual potential revenues (only US and Europe (untapped)) times a p/s of 8 -> $16 billion market cap, for only HLHS (unmet medical need...Hypoplastic Left Heart Syndrome...HLHS phase 2 results September 2026)...40 babies after 1 year (20:20) HLHS program may be eligible for PRV (priority review voucher) upon BLA approval (valued between $150-200 million) Incredible phase 2 Alzheimer’s results, granted RMAT fast-track - in talks with potential partners for phase 3 50 patents 60 patents pending

$ENVA: Enova International withdraws bank regulatory applications; reaffirms guidance and intends to accelerate repurchases.

$ENVA Hey! How could the spread in after hours yesterday be $30 or 14%? This must be some kind of fraud.